Clinical and economic outcomes of adding [18F]FES PET/CT in estrogen receptor status identification in metastatic and recurrent breast cancer in the US.
Saved in:
| Title: | Clinical and economic outcomes of adding [18F]FES PET/CT in estrogen receptor status identification in metastatic and recurrent breast cancer in the US. |
|---|---|
| Authors: | Munter-Young, Regina1 (AUTHOR) regina.young@gehealthcare.com, Fuentes-Alburo, Adolfo2 (AUTHOR), DiGregorio, Nicholas3 (AUTHOR), Neeser, Kurt4 (AUTHOR), Gultyaev, Dmitry4 (AUTHOR) |
| Source: | PLoS ONE. 5/14/2024, Vol. 19 Issue 5, p1-18. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19326203 |
|---|---|
| DOI: | 10.1371/journal.pone.0302486 |
